Propanc Biopharma Inc (PPCB)
0.0019
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Propanc Biopharma Enterprise Value: 1.221M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.221M |
| May 30, 2024 | 1.221M |
| May 29, 2024 | 1.086M |
| May 28, 2024 | 1.103M |
| May 24, 2024 | 1.086M |
| May 23, 2024 | 1.036M |
| May 22, 2024 | 1.036M |
| May 21, 2024 | 1.093M |
| May 20, 2024 | 1.011M |
| May 17, 2024 | 1.019M |
| May 16, 2024 | 1.019M |
| May 15, 2024 | 1.019M |
| May 14, 2024 | 1.053M |
| May 13, 2024 | 1.045M |
| May 10, 2024 | 1.012M |
| May 09, 2024 | 1.012M |
| May 08, 2024 | 1.066M |
| May 07, 2024 | 1.033M |
| May 06, 2024 | 1.009M |
| May 03, 2024 | 0.9895M |
| May 02, 2024 | 0.9895M |
| May 01, 2024 | 0.9895M |
| April 30, 2024 | 1.012M |
| April 29, 2024 | 1.000M |
| April 26, 2024 | 1.012M |
| Date | Value |
|---|---|
| April 25, 2024 | 1.022M |
| April 24, 2024 | 1.017M |
| April 23, 2024 | 1.033M |
| April 22, 2024 | 1.022M |
| April 19, 2024 | 1.022M |
| April 18, 2024 | 1.012M |
| April 17, 2024 | 1.055M |
| April 16, 2024 | 1.044M |
| April 15, 2024 | 1.055M |
| April 12, 2024 | 1.088M |
| April 11, 2024 | 1.088M |
| April 10, 2024 | 1.121M |
| April 09, 2024 | 1.121M |
| April 08, 2024 | 1.066M |
| April 05, 2024 | 1.077M |
| April 04, 2024 | 1.121M |
| April 03, 2024 | 1.132M |
| April 02, 2024 | 1.154M |
| April 01, 2024 | 1.150M |
| March 28, 2024 | 1.082M |
| March 27, 2024 | 1.119M |
| March 26, 2024 | 1.056M |
| March 25, 2024 | 1.062M |
| March 22, 2024 | 1.074M |
| March 21, 2024 | 1.072M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.5979M
Minimum
Dec 13 2021
2.979M
Maximum
Dec 31 2019
1.316M
Average
1.012M
Median
Apr 18 2024
Enterprise Value Benchmarks
| Incannex Healthcare Inc | 35.93M |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5267M |
| Total Expenses (Quarterly) | 0.4209M |
| EPS Diluted (Quarterly) | -0.01 |
| Earnings Yield | -11.24K% |